GLP-1 medications can cause nausea, vomiting, and reduced fluid intake, and dehydration is already one of their more common side effects
Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 19 GLP-1 Agonists in Adolescent Obesity: A Narrative Review of Single, Dual, and Triple Agonists Authors Abid M, Sheikh KS, Ahmad MS, Jiang H Received 19 January 2026 Accepted for publication 17 March 2026 Published 12 June 2026 Volume 2026:19 566414 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Donald McClain Mahroz Abid, 1 Khizer Sohail Sheikh, 1 Muhammad Shahbaz Ahmad, 2 Hongwei Jiang 1 1 Department of Metabolism and Endocrinology, Endocrine and Metabolic Disease Center, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, Peoples Republic of China
These systems play important roles in cellular structure, communication, and tissue biology, making them key areas of interest in peptide research
Novak, N
Patients who continue eating adequate protein, exercising regularly, and managing stress while using compounded semaglutide report better satisfaction, faster results, and easier long-term weight maintenance than those relying solely on medication without lifestyle support
It could be used as a therapeutic agent to help manage health issues related to GH and IGF-I levels [1]
